SEC Filing Details
Document Details
Form
Filing Date
Apr 25, 2024
Document Date
Apr 16, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Recursion Pharmaceuticals, Inc.
Issuer
RECURSION PHARMACEUTICALS, INC.
Filer
KHAN NAJAT